Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial
Not Applicable
Completed
- Conditions
- Pain, BackPain, NeuropathicChronic PainIntractable PainLow Back Pain
- Interventions
- Device: Spinal Cord Stimulation
- Registration Number
- NCT04909593
- Lead Sponsor
- Boston Scientific Corporation
- Brief Summary
The purpose of the study is to assess the feasibility of using information extracted from physiologic signals to automatically adjust stimulation in patients undergoing Spinal Cord Stimulation (SCS).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
- Study candidate is undergoing a temporary SCS trial of commercially approved BSC neurostimulator system, per local directions for use (DFU).
- Subject signed a valid, EC/IRB-approved informed consent form.
- Age 18 or above, or above legal age and willing and capable of giving informed consent specific to national law when written informed consent is obtained.
- In the clinician best judgment, subject is able to distinguishably describe quality and location of sensation and pain.
Key
Exclusion Criteria
- Subject meets any contraindication in BSC neurostimulation system local DFU.
- Investigator-suspected gross lead migration during the SCS trial period which may preclude the study candidate from receiving adequate SCS therapy.
- Subject is currently diagnosed with cognitive impairment, or exhibits any characteristic, that in the clinician's best judgement would limit study candidate's ability to assess and report sensation information.
- Subject is currently diagnosed with a physical impairment, or exhibits a condition that would limit study candidate's ability to complete study assessments.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Spinal Cord Stimulation Spinal Cord Stimulation SCS trial systems including external trial stimulators, lead(s)/extensions(s), and operating room (OR) cable(s)/extender(s) and optional sensor.
- Primary Outcome Measures
Name Time Method Perception Threshold Programming Visit (up to 15 days post-screening) Percent change in patient's perceiving spinal cord stimulation (i.e. Perception Threshold) when going from a reclining to sitting position in a reclining chair
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
PCPMG Clinical Research Unit, LLC
🇺🇸Greenville, South Carolina, United States
PCPMG Clinical Research Unit, LLC🇺🇸Greenville, South Carolina, United StatesBoston Scientific Clinical Research ManagerContact855-213-9890BSNClinicalTrials@bsci.comEric P Loudermilk, MDPrincipal Investigator